[1]
Kokolakis, G. et al. 2020. Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy. Acta Dermato-Venereologica. 100, 14 (Jul. 2020), 1–6. DOI:https://doi.org/10.2340/00015555-3545.